ArticleLiver cancer2026

Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional Study.

François Villeret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.